Br J Cancer: Computer fault scanning (CT) has no advantage over chest XR in the initial assessment of pregnancy nourishing cell tumor formation

Pregnancy nourishing cell tumors (GTNs) are usually classified using the International Federation of Obstetrics and Gynecology (FIGO) scoring system to identify patients as low-risk (score ≤6) or high-risk (score≥7) for single-drug chemotherapy resistance (SACR).
FIGO scoring system typically uses chest X-rays (CXRs) as a criterion for evaluating tumor lung metastasis.
computer fault scan (CT) is more sensitive to lung metastasis than chest X-ray (CXR) testing, but it is not clear how it affects patient outcomes.
A total of 589 patients who underwent GTN assessment were both tested for CXR and CT in the study, comparing FIGO scores based on CXR and CT pulmonary metastasis imaging.
treatment decisions are based primarily on CXR.
compared the number of transfers, risk scores, and risk categories of patients tested with CXR and CT.
Compared to the patient's prognosis, the occurrence of SACR, the normal time of TNhCG (normal fluffy membrane gonadotrophic hormone) and primary chemotherapy resistance (PCR), CT-related chest scores were assessed as the main factors affecting treatment decision-making.
results flowcharts showed that CT transfer tests and FIGO scores were higher than those of CXR.
THE CT test had a higher FIGO score in 188 patients (31.9%), 43 of which were reclassified from low risk to high risk, and 23 of those patients (53.5%) received healing monotherapy.
the SACR has a higher rate when the score or risk group changes.
the transfer of CXR detection rather than CT detection can extend TNhCG time.
analysis shows that there is no difference between CXR and CT when predicting PCR.
, the results show that CT can improve patient sACR prediction, but does not affect overall treatment outcomes, TNhCG or PCR prediction.
CXR-based evaluation strategy because of low radiation doses and costs.
。